Al-Nakouzi, Nader http://orcid.org/0000-0002-4653-2884
Wang, Chris Kedong
Oo, Htoo Zarni
Nelepcu, Irina http://orcid.org/0000-0002-9208-6934
Lallous, Nada
Spliid, Charlotte B.
Khazamipour, Nastaran
Lo, Joey
Truong, Sarah
Collins, Colin
Hui, Desmond
Esfandnia, Shaghayegh
Adomat, Hans
Clausen, Thomas Mandel
Gustavsson, Tobias
Choudhary, Swati
Dagil, Robert http://orcid.org/0000-0002-5594-0716
Corey, Eva http://orcid.org/0000-0002-9244-3807
Wang, Yuzhuo
Chauchereau, Anne
Fazli, Ladan
Esko, Jeffrey D.
Salanti, Ali
Nelson, Peter S.
Gleave, Martin E.
Daugaard, Mads http://orcid.org/0000-0001-8383-055X
Funding for this research was provided by:
Gouvernement du Canada | Instituts de Recherche en Santé du Canada | CIHR Skin Research Training Centre (PJT-153092)
Prostate Cancer Canada (RS2014-02)
Mitacs (IT06057)
Article History
Received: 28 May 2021
Accepted: 3 August 2022
First Online: 13 August 2022
Competing interests
: M.D., A.S., and T.M.C., are co-founders and shareholders of VAR2 Pharmaceuticals; N.AN., T.G., R.D., S.C., are employed by, and/or external consultants for, VAR2 Pharmaceuticals. The remaining authors declare no competing interests.